# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001087294-25-000020
Filing Date
2025-11-07
Accepted
2025-11-07 17:05:30
Documents
59
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20250930.htm iXBRL | 10-Q | 939018
2 | EX-31.1 | a2025q3-exhibit311.htm | EX-31.1 | 12511
3 | EX-31.2 | a2025q3-exhibit312.htm | EX-31.2 | 12504
4 | EX-32.1 | a2025q3-exhibit321.htm | EX-32.1 | 6777
| Complete submission text file | 0001087294-25-000020.txt |  | 4734303

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20250930.xsd | EX-101.SCH | 33210
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20250930_cal.xml | EX-101.CAL | 54398
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20250930_def.xml | EX-101.DEF | 130100
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20250930_lab.xml | EX-101.LAB | 458288
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20250930_pre.xml | EX-101.PRE | 312160
61 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20250930_htm.xml | XML | 486827

Mailing Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE TN 37203
Business Address 1600 WEST END AVENUE SUITE 1300 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 621765329 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 251463498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)